MCCA
MRK icon

Mill Creek Capital Advisors’s Merck MRK Stock Holding History

Mill Creek Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$714K Sell
5,935
-140
-2% -$16.2K 0.01% 136
2025
Q4 		$639K Sell
6,075
-2,713
-31% -$255K 0.01% 146
2025
Q3 		$738K Buy
8,788
+484
+6% +$39.9K 0.02% 136
2025
Q2 		$657K Sell
8,304
-3,314
-29% -$263K 0.01% 137
2025
Q1 		$1.04M Buy
11,618
+192
+2% +$17.9K 0.03% 114
2024
Q4 		$1.14M Buy
11,426
+1,601
+16% +$165K 0.03% 110
2024
Q3 		$1.12M Sell
9,825
-942
-9% -$112K 0.03% 104
2024
Q2 		$1.33M Buy
10,767
+242
+2% +$31.2K 0.03% 101
2024
Q1 		$1.39M Sell
10,525
-336
-3% -$41.4K 0.04% 90
2023
Q4 		$1.18M Buy
10,861
+309
+3% +$32.1K 0.04% 92
2023
Q3 		$1.09M Sell
10,552
-1,241
-11% -$134K 0.04% 92
2023
Q2 		$1.36M Buy
11,793
+1,082
+10% +$123K 0.04% 87
2023
Q1 		$1.14M Sell
10,711
-168
-2% -$18.1K 0.04% 95
2022
Q4 		$1.21M Buy
+10,879
New +$1.11M 0.05% 86

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Mill Creek Capital Advisors's MRK Position: Q1 2026 in Review

Mill Creek Capital Advisors reduced its Merck (MRK) stake by 2.3% in Q1 2026, selling an estimated $16.2K and leaving 5,935 shares worth $714K. The position accounts for 0.01% of the portfolio, ranked #136.

Mill Creek Capital Advisors first reported a position in MRK in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.39M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Mill Creek Capital Advisors held 5,935 shares of Merck worth $714K as of Q1 2026.
  • Mill Creek Capital Advisors sold 140 Merck shares in Q1 2026, an estimated $16.2K.
  • Merck made up 0.01% of Mill Creek Capital Advisors's portfolio in Q1 2026, its #136 holding.
  • Mill Creek Capital Advisors first reported a position in Merck in Q4 2022 and has held it in 14 quarters since.
  • Mill Creek Capital Advisors's Merck position peaked at $1.39M in Q1 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Mill Creek Capital Advisors's 13F filing for Q1 2026, filed 14 May 2026.